Clinical Scorecard: Impact of the Personalized Glaucoma Coaching Program on Adherence to Medication: Support, Educate, Empower Approach
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Adults with glaucoma self-reporting poor medication adherence (defined as adherence of 85% or lower).
Care Setting
Key Highlights
The SEE trial was a parallel, nonmasked, 1:1 randomized clinical trial, enhancing the validity of the findings.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Use electronic monitoring to assess medication adherence.
Regularly measure intraocular pressure (IOP) during follow-up visits, ideally every 1-3 months.
Risks
Patient & Prescribing Data
Personalized coaching and reminders operationalized through tailored multimedia education and motivational interviewing can enhance adherence to glaucoma medications.
Clinical Best Practices
Incorporate patient engagement strategies, such as shared decision-making, to improve adherence.
Thomas Aller, OD, provides in-depth overviews of each myopia management option—pharmacologic therapy, soft contact lenses, orthokeratology, spectacle lenses, and environmental and behavioral interventions—so clinicians can not only provide the right option to each patient, but also address the larger economic and societal burdens of myopia.
